Breast Cancer Clinical Trial
Nutrition-Related Biomarkers in Predicting Breast Cancer Risk in Women
Summary
RATIONALE: Studying samples of blood from patients with cancer in the laboratory may help doctors learn more about nutrition-related changes that identify biomarkers related to cancer. It may also help doctors predict a woman's risk of developing breast cancer.
PURPOSE: This laboratory study is looking at nutrition-related biomarkers in predicting breast cancer risk in women.
Full Description
OBJECTIVES:
To complete characterization of metabolic serotypes based on the metabolome, and to adapt these profiles for human epidemiological studies.
To determine the extent to which metabolic profiles that are reflective of or independent of long-term caloric intake predict breast cancer risk in nested case-control studies.
To identify critical serum metabolites.
OUTLINE: Laboratory studies, including metabolome profiling by high performance liquid chromatography; and small molecule identification by mass spectroscopy, are performed on previously collected blood samples.
Eligibility Criteria
DISEASE CHARACTERISTICS:
Meets 1 of the following criteria:
Confirmed breast cancer that was diagnosed at least 2 years after blood sample collection (case)
No prior diagnosis of cancer
Healthy participant (control)
Enrolled in the Nurses' Health Study
Banked blood samples available
Hormone receptor status not specified
PATIENT CHARACTERISTICS:
Menopausal status not specified
PRIOR CONCURRENT THERAPY:
Not specified
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Boston Massachusetts, 02115, United States
How clear is this clinincal trial information?

Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.